Greystone Provides $31 Million Fannie Mae DUS® Loan in Washington State
Oct 24, 2016 14:17 pm UTC| Business
NEW YORK, Oct. 24, 2016 -- Greystone, a real estate lending, investment and advisory company, today announced it has provided a $31,000,000 Fannie Mae Delegated Underwriting and Servicing (DUS®) loan for the permanent...
Veterans Conference Calls Attention to Returning Vets’ Legal Problems
Oct 24, 2016 14:15 pm UTC| Business
SAN FRANCISCO, Oct. 24, 2016 -- Golden Gate University School of Law will hold its fourth Veterans Law Conference on November 3 in an ongoing effort to raise awareness of the legal, health, and employment issues...
Oct 24, 2016 14:12 pm UTC| Business
Dublin, Oct. 24, 2016 -- Research and Markets has announced the addition of the "3D Printing in Dentistry 2016: A Ten-Year Forecast and Opportunity Analysis" report to their offering. ...
Favro Introduces Its Online Collaboration Platform to The Enterprise
Oct 24, 2016 14:01 pm UTC| Business
UPPSALA, Sweden, Oct. 24, 2016 -- Favro, an online planning and collaboration tool, is launching its enterprise platform bringing agile management practices to global, large-scale workforces. Favro Enterprise comes from...
InSync to Showcase Cloud-Based Solutions & Services at MGMA 2016 Annual Conference
Oct 24, 2016 14:01 pm UTC| Business
TAMPA, Fla., Oct. 24, 2016 -- InSync Healthcare Solutions, a leading provider of cloud-based healthcare technology software, announced that it will exhibit at the Medical Group Management Association (MGMA) 2016 Annual...
Blue Buffalo Hires R&D Leader to Enhance Product Innovation and Advance Scientific Learning
Oct 24, 2016 14:00 pm UTC| Business
WILTON, Conn., Oct. 24, 2016 -- Blue Buffalo Company (Nasdaq:BUFF) announced that Greg Reinhart, PhD, has joined the company as Senior Vice President, Research Development. Dr. Reinhart will lead the Blue Buffalo RD...
Concert Pharmaceuticals, Inc. (Nasdaq: CNCE) to Ring The Nasdaq Stock Market Closing Bell
Oct 24, 2016 14:00 pm UTC| Business
ADVISORY, Oct. 24, 2016 -- What: Concert Pharmaceuticals, Inc. (Nasdaq:CNCE), a clinical stage biopharmaceutical company focused on applying itsDCE Platform®(deuterated chemical entity platform) to create novel...